Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Anticoccidial Drugs Market Expected to Grow Between 2025 And 2029?

In recent times, there’s been robust growth in the market size of anticoccidial drugs. Its expansion is projected from $1.27 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The substantial growth in the past can be linked to a rise in global cases of coccidiosis, heightened ownership of pet animals, widespread prevalence of coccidiosis, its economic implications, and increasing concerns about the safety of food and animal health.

What Growth Rate Is Anticipated for the Anticoccidial Drugs Market in the Coming Years?

The market for anticoccidial drugs is projected to experience substantial growth in the coming years, increasing to $1.81 billion by 2029 with a 7.2% compound annual growth rate (CAGR). This future growth is believed to be due to several factors. These include the expansion of veterinary healthcare, the escalating occurrence of coccidiosis in animals, a rise in the usage of synthetic drugs, an increasing requirement for feed additives, and the growth in livestock production. During the forecast period, specific trends are expected to drive the growth. These trends include increasing demand spurred by newly emerging strains of coccidiosis, a movement towards natural and alternative treatment procedures, more stringent regulatory scrutiny that inspires innovation, a rise in customer preference for antibiotic-free poultry products, improvements in drug delivery technology, an intensified emphasis on preventive healthcare practices, and a broadening application scope in the aquaculture and companion animal sectors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

Who Are the Leading Companies in the Anticoccidial Drugs Market?

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

What Are the Key Drivers of the Anticoccidial Drugs Market?

The anticoccidial drug market is predicted to grow due to the escalating demand for meat proteins. These proteins found naturally in the flesh of animals, contain critical amino acids that play vital roles in bodily functions. Consumer preference for protein-enriched foods, driven by increased disposable income, urbanization, population growth, and dietary changes, is fuelling demand for meat proteins. Anticoccidial drugs play a key role in modern livestock rearing, supporting animal health and productivity, and enabling farmers to meet the growing demand for meat proteins in a sustainable and efficient way. The Organization for Economic Co-operation and Development, based in France, and the Food and Agriculture Organization, based in Italy, reported in July 2023 that despite an estimated increase of 2% in global average per capita meat demand from the base period of 2020-2022 to 2032, the FAO meat price index saw a 10% increase in 2022 due to limited export supplies. Thus, the anticoccidial drug market is poised for expansion due to the growing demand for meat proteins.

Market Growth of Anticoccidial Drugs Driven by Upsurge in Poultry Farming

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

What Are the Key Market Segments in the Anticoccidial Drugs Industry?

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

What Are the Latest Trends in the Anticoccidial Drugs Market?

Top companies in the anticoccidial drugs market are centering on the development of innovative solutions such as synthetic coccidiostat with an aim to bolster efficacy, eradicate resistance growth, and to tackle evolving obstacles in poultry and livestock management. Synthetic coccidiostat is a chemically structured compound intended for the prevention or control of coccidiosis by restricting the growth and propagation of coccidia parasites in animals. For example, in March 2023, Zoetis, an animal health firm based in the US, introduced Avi-Deccox, a newly formulated synthetic coccidiostat for controlling coccidiosis in broiler chickens. This specific product attacks the pathogens Eimeria acervulina and Eimeria tenella which cause considerable financial damages in poultry farming. Similar to its initial version, Deccox, Avi-Deccox uses decoquinate as its primary active element. It addresses the escalating problem of resistance associated with the frequent utilization of ionophores in poultry farming by utilizing a different method of action, yielding a more efficient short-term knock-down effect.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

What Are the Key Regional Markets in the Anticoccidial Drugs Industry?

North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

This Report Delivers Insight On:

1. How big is the anticoccidial drugs market, and how is it changing globally?

2. Who are the major companies in the anticoccidial drugs market, and how are they performing?

3. What are the key opportunities and risks in the anticoccidial drugs market right now?

4. Which products or customer segments are growing the most in the anticoccidial drugs market?

5. What factors are helping or slowing down the growth of the anticoccidial drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model